中国畜牧兽医 ›› 2021, Vol. 48 ›› Issue (11): 4004-4013.doi: 10.16431/j.cnki.1671-7236.2021.11.010

• 动物营养与饲料科学 • 上一篇    下一篇

贞苓增免散对罗非鱼的安全性评价

何文娜1,2, 肖婷1,2, 何颖1,2, 周英宁2, 蒋冬福2, 卢敬专2, 陈忠伟2, 胡庭俊1   

  1. 1. 广西大学动物科学技术学院, 南宁 530004;
    2. 广西壮族自治区兽医研究所, 广西兽医生物技术重点实验室, 南宁 530001
  • 收稿日期:2021-03-07 出版日期:2021-11-20 发布日期:2021-11-01
  • 通讯作者: 陈忠伟, 胡庭俊 E-mail:heying921@163.com;tingjunhu@126.com
  • 作者简介:何文娜(1997-),女,河南淇县人,硕士生,研究方向:兽医药理与毒理病理学,E-mail:hewenna@st.gxu.edu.cn
  • 基金资助:
    广西创新驱动发展专项(桂科AA17204081、AA17204057、AA18118051);广西南宁市西乡塘区科学研究与技术开发计划项目(2019021601);南宁市科学研究与技术开发计划项目(20202090)

Safety Evaluation of Zhenling Zengmian Powder on Tilapia

HE Wenna1,2, XIAO Ting1,2, HE Ying1,2, ZHOU Yingning2, JIANG Dongfu2, LU Jingzhuan2, CHEN Zhongwei2, HU Tingjun1   

  1. 1. College of Animal Science and Technology, Guangxi University, Nanning 530004, China;
    2. Guangxi Key Laboratory of Veterinary Biotechnology, Guangxi Veterinary Research Institute, Nanning 530001, China
  • Received:2021-03-07 Online:2021-11-20 Published:2021-11-01

摘要: 试验旨在确定贞苓增免散在临床推荐剂量下对罗非鱼的安全性,研究罗非鱼使用剂量安全范围并综合评价药物的疗效,为临床合理用药提供重要依据与指导。试验分别设置空白组(基础饲粮)、1倍剂量组(含贞苓增免散0.4%)、3倍剂量组(含贞苓增免散1.2%)、5倍剂量组(含贞苓增免散2.0%)和10倍剂量组(含贞苓增免散4.0%)共5个组。连续饲喂30 d,分别在第15和30天检测罗非鱼的临床体征、血液生理生化指标、器官指数,并进行组织病理学观察。结果表明,各剂量组罗非鱼活动、摄食、体色、排泄等均良好,与空白组罗非鱼没有明显区别。0~15 d,增重率和特定生长率在1倍剂量组均最高,且均显著或极显著高于空白组(P<0.05;P<0.01),但其随着贞苓增免散剂量增加而减少;15~30 d贞苓增免散各剂量组增重率均极显著高于空白组(P<0.01)。各剂量组罗非鱼的血液生理生化指标中部分指标与空白组相比有显著差异,但均在正常范围内。0~15 d时各剂量组和15~30 d时1倍剂量组的罗非鱼脾脏指数均显著高于空白组(P<0.05)。显微镜下观察各组罗非鱼肝脏和脾脏组织切片,均未发现药物引起的细胞毒性变化。以上结果说明贞苓增免散在10倍推荐剂量及以下连续饲喂罗非鱼30 d具有较好的安全性,将其作为饲料添加剂能提高罗非鱼生长性能、增强免疫力,对推动罗非鱼养殖快速高效发展具有重要意义。

关键词: 贞苓增免散; 罗非鱼; 生理指标; 生化指标

Abstract: The purpose of the trial was to determine the safety of Zhenling Zengmian powder on tilapia at the recommended clinical dose, study the safe range of tilapia dose and comprehensively evaluate the efficacy of the drug, so as to provide important basis and guidance for clinical rational drug use. Five groups were set up in this experiment, including blank group (basic feed), 1 time dose group (including 0.4% of Zhenling Zengmian powder), 3 times dose group (including 1.2% of Zhenling Zengmian powder), 5 times dose group (including 2.0% of Zhenling Zengmian powder), and 10 times dose group (including 4.0% of Zhenling Zengmian powder). The tilapia were fed continuously for 30 days, and the clinical signs, blood physiological and biochemical indexes, organ index and histopathology of tilapia were detected on the 15th and 30th day, respectively. The results showed that the activity, feeding, body color and excretion of tilapia in each dose group were good, which was not significantly different from that in the blank group. The weight gain rate and specific growth rate were the highest in the 1 time dose group, which were significantly or extremely significantly higher than those in the blank group (P<0.05;P<0.01), but decreased with the increase of the amount of Zhenling Zengmian powder from 0 to 15 days. From 15 to 30 days, the weight gain rate of each dose group of Zhenling Zengmian powder was significantly higher than that of the blank group (P<0.01). Some of the blood physiological and biochemical indexes of tilapia in each dose group were significantly different from those in the blank group, but they were all within the normal range. The tilapia spleen index of each dose group at 0-15 days and the 1 time dose group at 15-30 days were significantly higher than that of the blank group (P<0.05). The liver and spleen sections of tilapia in each group were observed under microscope, and no cytotoxic changes caused by drugs were found. The above results showed that Zhenling Zengmian powder was safe to feed tilapia for continuously 30 days at or below the 10 times of recommended dose. As a feed additive, it could improve the growth performance and enhance immunity of tilapia, which was of great significance to promote the rapid and efficient development of tilapia culture.

Key words: Zhenling Zengmian powder; tilapia; physiological index; biochemical index

中图分类号: